Humana Inc.

HUM · Healthcare · · USD

401.54 USD

0.00 (-1.23%)

● Updated 2026-09-07 19:34 Saudi Time ↻ Refresh

Short-term Mid-term Long-term

Fahodi Score STRONG BUY Short-term (Swing)

/ 100

Technical 100

Trend & RS 86

Momentum 77

Fundamental (0%) 78

Macro 64

Liquidity 43

Component	Score	Weight
Technical	100.0	40%
Trend & RS	86.4	20%
Momentum	77.1	20%
Fundamental	77.8	0%
Macro	64.4	15%
Liquidity	43.1	5%

Trade Setup

Entry	401.54
Stop Loss	375.52 (6.5%)
Target 1 (1:1)	427.56 (+6.5%)
Target 2 (2:1)	453.58 (+13.0%)

ATR(14)	13.01 (3.2%)
Risk per Share	26.02
Reward:Risk	2:1

ATR-based levels. Adjust for support/resistance zones.

Factor Profile

Factor	Score	Z
Value	52.7	+0.11
Momentum	77.1	+1.08
Quality	30.3	-0.79
Composite	53.4

Quality Scores

Piotroski F-Score 7 /9 — Strong

✓ ✓ ✗ ✗ ✓ ✓ ✓ ✓ ✓

1. Positive Net Income 2. Positive Roa 3. Positive Cfo 4. Quality Earnings 5. Lower Leverage 6. Higher Liquidity 7. No Dilution 8. Higher Gross Margin 9. Higher Asset Turnover

Altman Z-Score Insufficient Data

Valuation vs Peers Fair Value

Metric	Stock	Sector	vs Peers
P/E Ratio	38.0	22.0	+73% above
P/B Ratio	2.5	4.0	Below
Dividend Yield	88.0%	1.5%	Above avg

Comparing against Healthcare median multiples.

Intrinsic Value (DCF) Overvalued

Intrinsic Value

329.14

Market Price

401.54

Upside

-18.0%

Margin of Safety	-22.0%
Stage 1 PV (5yr FCF)	7,794,003,376
Terminal Value PV	31,728,809,991
Total Enterprise Value	39,522,813,367

Assumptions

Base FCF	1,014,438,445
Growth Rate (5yr)	25.0%
Terminal Growth	2.5%
Discount Rate (WACC)	9.0%

2-stage DCF: 5yr projected FCF + Gordon Growth terminal value. Estimates only — adjust growth and WACC for your own assumptions.

Position Sizing — Kelly Criterion

4.5%

Recommended Size

53.96%

Full Kelly

26.98%

Half Kelly

5.0%

Max Cap (Moderate)

Kelly inputs derived from quant score 84/100. Estimated win rate 65%, avg win 10.1%, avg loss 3.3%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.

BEAR Regime: BEAR (20% confidence) — position size reduced 10%

Signal Summary STRONG BUY

Bullish Signals

Bearish Signals

59.41

RSI(14)

5.2475

MACD

Relative Strength (RS) NEUTRAL

/ 99

RS Rating

✓ O'Neil PASS (≥80)

RS vs SPY	→ FLAT (+10.3% vs SPY 3M)
RS vs Sector	INLINE (Healthcare)
RS New High	No (46d since high)
Sector Outperformance	+7.2% (3M)

RS Line — stock / SPY (90 bars)

← older newer →

RS vs SPY 50-day SMA of RS

NEUTRAL: In line with the market — no strong outperformance or underperformance.

Technical Indicators

Indicator	Value	Signal
Rsi	59.41	NEUTRAL
Macd	5.2475	BULLISH
Ma Cross	388.35 / 278.69	GOLDEN CROSS
Trend Short		ABOVE SMA50
Trend Long		ABOVE SMA200
Bollinger		MIDDLE
Volume	0.8x	NORMAL

Key Levels

Level	Price
52-Week High	428.88
Bollinger Upper	404.68
SMA(200)	278.69
SMA(50)	388.35
SMA(20)	387.9
Current Price	401.54
Bollinger Lower	371.12
52-Week Low	163.11
ATR(14)	13.01

Advanced Technical Analysis

Click to expand

Wyckoff Phase & Volume Spread Analysis

Wyckoff Phase

Insufficient data for Wyckoff analysis.

Volume Spread Analysis (last 5 bars)

Date	Signal	Vol	Description
2026-08-31	Normal	1.05x	Normal bar — no special VSA pattern
2026-09-01	Normal	1.09x	Normal bar — no special VSA pattern
2026-09-02	Normal	1.17x	Normal bar — no special VSA pattern
2026-09-03	Normal	0.79x	Normal bar — no special VSA pattern
2026-09-04	Normal	0.8x	Normal bar — no special VSA pattern

Ichimoku Cloud BULLISH

Line	Value	Status
Tenkan-sen (9)	397.23	Above Kijun
Kijun-sen (26)	383.60	Base line
Senkou A	390.41	Leading span A
Senkou B	390.55	Leading span B
Cloud	390.41 – 390.55	Bearish (Red)
Price vs Cloud	401.54	Above Cloud
Chikou Span	363.86	Bullish
Alignment Score	3/4	BULLISH